Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia [Basic Sciences]

Conclusions— Rosiglitazone treatment improves long-term white matter integrity after cerebral ischemia, at least, in part, by promoting oligodendrogenesis and facilitating microglial polarization toward the beneficial M2 phenotype.

http://stroke.ahajournals.org/cgi/content/short/46/9/2628?rss=1

Source: Stroke - August 24, 2015 Category: Neurology Authors: Han, L., Cai, W., Mao, L., Liu, J., Li, P., Leak, R. K., Xu, Y., Hu, X., Chen, J. Tags: Other Stroke Treatment - Medical Basic Sciences Source Type: research